Serotonin transporter gene polymorphisms: Relation with platelet serotonin level in patients with primary Sjogren's syndrome

被引:4
作者
Markeljevic, J. [1 ]
Sarac, H. [2 ,3 ]
Bozina, N. [4 ]
Henigsberg, N. [3 ]
Simic, M. [5 ]
Cicin-Sain, L. [6 ]
机构
[1] Univ Zagreb, Sch Med, Dept Internal Med, Univ Hosp Sestre Milosrdnice, Zagreb 10000, Croatia
[2] Univ Clin Hosp Ctr Zagreb, Dept Neurol, Zagreb 10000, Croatia
[3] Univ Zagreb, Sch Med, Croatian Inst Brain Res, Zagreb 10000, Croatia
[4] Univ Zagreb, Sch Med, Univ Hosp Zagreb, Dept Lab Diagnost, Zagreb 10000, Croatia
[5] Inst Immunol, HR-10000 Zagreb, Croatia
[6] Rudjer Boskovic Inst, Lab Neurochem & Mol Neurobiol, Dept Mol Biol, Zagreb 10000, Croatia
关键词
Serotonin transporter polymorphism; 5-HTTLPR/rs25531; 5-HTTVNTRin2; Platelet serotonin; Sjogren syndrome; PROMOTER; ASSOCIATION; TRYPTOPHAN; VARIANTS; GENOTYPES; REGION; ALLELE; GAIN; SERT;
D O I
10.1016/j.jneuroim.2015.04.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Significantly lower platelet serotonin level (PSL) in patients with primary Sjogren's syndrome (pSS) than in healthy controls has been reported in our prior studies. In the present report, we demonstrated effect of functional polymorphisms in the serotonin transporter gene (5-HTT) on PSL We describe a group of 61 pSS patients and 100 healthy individuals subjects, who received PSL measurement in our prior study. All subjects were genotyped for the promoter 5-HTTLPR (US), rs25531 (A/G) and intronic 5-HTTVNTRin2 (Us) polymorphisms. Overall, the presence of 5-HTTVNTRin2 ss genotype was associated with significantly lower PSL in pSS patients, not in healthy controls. Reduced PSL in pSS patients is in line with hypothesis of association between chronic immunoinflammation and 5-HT system dysregulation, identifying additional mechanisms such as altered 5-HT transport as potential genetic factor contributing to PSL depletion. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:104 / 109
页数:6
相关论文
共 50 条
[1]   5-HT and the immune system [J].
Ahern, Gerard P. .
CURRENT OPINION IN PHARMACOLOGY, 2011, 11 (01) :29-33
[2]   Serotonin transporter gene polymorphisms and treatment-resistant depression [J].
Bonvicini, Cristian ;
Minelli, Alessandra ;
Scassellati, Catia ;
Bortolomasi, Marco ;
Segala, Matilde ;
Sartori, Riccardo ;
Giacopuzzi, Mario ;
Gennarelli, Massimo .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (06) :934-939
[3]  
Bozina Nada, 2006, Psychiatr Danub, V18, P83
[4]   Association study of olanzapine-induced weight gain and therapeutic response with SERT gene polymorphisms in female schizophrenic patients [J].
Bozina, Nada ;
Medved, Vesna ;
Kuzman, Martina Rojnic ;
Sain, Ivica ;
Sertic, Jadranka .
JOURNAL OF PSYCHOPHARMACOLOGY, 2007, 21 (07) :728-734
[5]   Plasma serotonin levels and the platelet serotonin transporter [J].
Brenner, B. ;
Harney, J. T. ;
Ahmed, B. A. ;
Jeffus, B. C. ;
Unal, R. ;
Mehta, J. L. ;
Kilic, F. .
JOURNAL OF NEUROCHEMISTRY, 2007, 102 (01) :206-215
[6]   Platelets can enhance vascular permeability [J].
Cloutier, Nathalie ;
Pare, Alexandre ;
Farndale, Richard W. ;
Schumacher, H. Ralph ;
Nigrovic, Peter A. ;
Lacroix, Steve ;
Boilard, Eric .
BLOOD, 2012, 120 (06) :1334-1343
[7]   Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism [J].
Coutinho, AM ;
Oliveira, G ;
Morgadinho, T ;
Fesel, C ;
Macedo, TR ;
Bento, C ;
Marques, C ;
Ataíde, A ;
Miguel, T ;
Borges, L ;
Vicente, AM .
MOLECULAR PSYCHIATRY, 2004, 9 (03) :264-271
[8]  
Davies NWS, 2010, INT J TRYPTOPHAN RES, V3, P121
[9]  
Emamian E. S., 2006, ACR ARHP SCI M, P58
[10]   Neural immune pathways and their connection to inflammatory diseases [J].
Eskandari, F ;
Webster, JI ;
Sternberg, EM .
ARTHRITIS RESEARCH & THERAPY, 2003, 5 (06) :251-265